← Back to Search

Observational for Blood Cancers

N/A
Recruiting
Led By John B. Kisiel, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to study completion (estimate 20 years)
Awards & highlights

Study Summary

This study is being done to establish "normal' values for a new blood test and urine test approach to cancer screening. Patients undergo blood and urine sample collection on study. Patients' medical records are reviewed.

Eligible Conditions
  • Blood Cancers
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to study completion (estimate 20 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to study completion (estimate 20 years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biospecimen archive
Blood level distributions of methylated DNA tumor markers
Detection of cancer using urine samples

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo blood and urine sample collection on study. Patients' medical records are reviewed.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,233 Previous Clinical Trials
3,761,832 Total Patients Enrolled
John B. Kisiel, M.D.Principal InvestigatorMayo Clinic in Rochester
3 Previous Clinical Trials
6,650 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5702 spots leftby Dec 2035